Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL).

Turki AT, Rashidi-Alavijeh J, Dürig J, Gerken G, Rath PM, Witzke O.

BMC Infect Dis. 2017 Dec 28;17(1):797. doi: 10.1186/s12879-017-2877-8.

2.

Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan.

Sun KS, Tsai CF, Chen SC, Huang WC.

PLoS One. 2017 Oct 19;12(10):e0186422. doi: 10.1371/journal.pone.0186422. eCollection 2017.

3.

Atypical Presentation of Isolated Cerebral Aspergillosis in a Renal Allograft Recipient.

Patel MH, Vanikar AV, Patel HV, Patel RD.

J Clin Diagn Res. 2017 Jul;11(7):DD01-DD02. doi: 10.7860/JCDR/2017/27919.10288. Epub 2017 Jul 1.

4.

Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.

Petraitis V, Petraitiene R, McCarthy MW, Kovanda LL, Zaw MH, Hussain K, Shaikh N, Maung BBW, Sekhon NK, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00305-17. doi: 10.1128/AAC.00305-17. Print 2017 Sep.

PMID:
28696236
5.

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.

Kovanda LL, Kolamunnage-Dona R, Neely M, Maertens J, Lee M, Hope WW.

Clin Infect Dis. 2017 Jun 1;64(11):1557-1563. doi: 10.1093/cid/cix198.

6.

Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole.

Bunskoek PE, Seyedmousavi S, Gans SJ, van Vierzen PB, Melchers WJ, van Elk CE, Mouton JW, Verweij PE.

Med Mycol Case Rep. 2017 Apr 1;16:16-19. doi: 10.1016/j.mmcr.2017.03.005. eCollection 2017 Jun.

7.

Updated practice guidelines for the diagnosis and management of aspergillosis: challenges and opportunities.

Alevizakos M, Farmakiotis D, Mylonakis E.

J Thorac Dis. 2016 Dec;8(12):E1767-E1770. doi: 10.21037/jtd.2016.12.71. No abstract available.

8.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE.

Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.

9.

Treatment of Disseminated Aspergillosis with Posaconazole in 10 Dogs.

Corrigan VK, Legendre AM, Wheat LJ, Mullis R, Johnson B, Bemis DA, Cepero L.

J Vet Intern Med. 2016 Jan-Feb;30(1):167-73. doi: 10.1111/jvim.13795. Epub 2015 Nov 14.

10.

Serum galactomannan levels in the diagnosis of invasive aspergillosis.

Okuturlar Y, Ozkalemkas F, Ener B, Serin SO, Kazak E, Ozcelik T, Ozkocaman V, Ozkan HA, Akalin H, Gunaldi M, Ali R.

Korean J Intern Med. 2015 Nov;30(6):899-905. doi: 10.3904/kjim.2015.30.6.899. Epub 2015 Oct 30.

11.

Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis.

Han SB, Kim SK, Lee JW, Yoon JS, Chung NG, Cho B, Jeong DC, Kang JH, Kim HK, Lee DG, Lee HS, Im SA.

BMC Infect Dis. 2015 Jul 14;15:271. doi: 10.1186/s12879-015-1014-9.

12.

Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.

Neofytos D, Railkar R, Mullane KM, Fredricks DN, Granwehr B, Marr KA, Almyroudis NG, Kontoyiannis DP, Maertens J, Fox R, Douglas C, Iannone R, Kauh E, Shire N.

PLoS One. 2015 Jun 24;10(6):e0129022. doi: 10.1371/journal.pone.0129022. eCollection 2015.

13.

Invasive fungal infections in transplant recipients.

Vazquez JA, Miceli MH, Alangaden G.

Ther Adv Infect Dis. 2013 Jun;1(3):85-105. doi: 10.1177/2049936113491936. Review.

14.

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.

Vergidis P, Razonable RR, Wheat LJ, Estes L, Caliendo AM, Baden LR, Wingard JR, Baddley J, Assi M, Norris S, Chandrasekar P, Shields R, Nguyen H, Freifeld A, Kohler R, Kleiman M, Walsh TJ, Hage CA.

J Clin Microbiol. 2014 Jun;52(6):2199-201. doi: 10.1128/JCM.00285-14. Epub 2014 Apr 9.

15.

Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic response.

Krel M, Petraitis V, Petraitiene R, Jain MR, Zhao Y, Li H, Walsh TJ, Perlin DS.

Antimicrob Agents Chemother. 2014 Jun;58(6):3373-8. doi: 10.1128/AAC.02482-14. Epub 2014 Mar 31.

16.

Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in Korea.

Kim SJ, Cheong JW, Min YH, Choi YJ, Lee DG, Lee JH, Yang DH, Lee SM, Kim SH, Kim YS, Kwak JY, Park J, Kim JY, Kim HG, Kim BS, Ryoo HM, Jang JH, Kim MK, Kang HJ, Cho IS, Mun YC, Jo DY, Kim HY, Park BB, Kim JS.

J Korean Med Sci. 2014 Jan;29(1):61-8. doi: 10.3346/jkms.2014.29.1.61. Epub 2013 Dec 26.

17.

Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome.

Barton RC.

Scientifica (Cairo). 2013;2013:459405. doi: 10.1155/2013/459405. Epub 2013 Jan 14. Review.

18.

Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation.

Ghosh I, Raina V, Kumar L, Sharma A, Bakhshi S, Iqbal S.

Indian J Med Paediatr Oncol. 2013 Apr;34(2):74-9. doi: 10.4103/0971-5851.116181.

19.

Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.

Schwarzinger M, Sagaon-Teyssier L, Cabaret O, Bretagne S, Cordonnier C; PREVERT Investigators.

PLoS One. 2013 Jun 14;8(6):e65776. doi: 10.1371/journal.pone.0065776. Print 2013.

20.

Advancing the Field: Evidence for New Management Strategies in Invasive Fungal Infections.

Morrissey CO.

Curr Fungal Infect Rep. 2013 Mar;7(1):51-58. Epub 2013 Jan 11.

Supplemental Content

Support Center